vs
CF BANKSHARES INC.（CFBK）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
CF BANKSHARES INC.的季度营收约是Protalix BioTherapeutics, Inc.的1.7倍（$15.7M vs $9.1M），CF BANKSHARES INC.净利率更高（40.0% vs -60.3%，领先100.4%），CF BANKSHARES INC.同比增速更快（12.6% vs -49.9%），CF BANKSHARES INC.自由现金流更多（$18.2M vs $1.6M），过去两年CF BANKSHARES INC.的营收复合增速更高（13.7% vs -6.7%）
CF BANKSHARES INC.是一家美国区域性银行控股企业，通过旗下社区银行子公司运营，提供全方位个人及商业银行解决方案，包括存款产品、各类贷款、财富管理服务及数字银行工具，主要服务美国中西部地区的个人消费者和中小企客户。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
CFBK vs PLX — 直观对比
营收规模更大
CFBK
是对方的1.7倍
$9.1M
营收增速更快
CFBK
高出62.6%
-49.9%
净利率更高
CFBK
高出100.4%
-60.3%
自由现金流更多
CFBK
多$16.6M
$1.6M
两年增速更快
CFBK
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.7M | $9.1M |
| 净利润 | $5.7M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 43.4% | -51.1% |
| 净利率 | 40.0% | -60.3% |
| 营收同比 | 12.6% | -49.9% |
| 净利润同比 | 29.9% | -184.8% |
| 每股收益（稀释后） | $0.88 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFBKPLX
| Q4 25 | $15.7M | $9.1M | ||
| Q3 25 | $15.5M | $17.9M | ||
| Q2 25 | $15.6M | $15.7M | ||
| Q1 25 | $14.1M | $10.1M | ||
| Q4 24 | $14.0M | $18.2M | ||
| Q3 24 | $13.1M | $18.0M | ||
| Q2 24 | $12.6M | $13.5M | ||
| Q1 24 | $12.2M | — |
净利润CFBKPLX
| Q4 25 | $5.7M | $-5.5M | ||
| Q3 25 | $2.3M | $2.4M | ||
| Q2 25 | $5.0M | $164.0K | ||
| Q1 25 | $4.4M | $-3.6M | ||
| Q4 24 | $4.4M | $6.5M | ||
| Q3 24 | $4.2M | $3.2M | ||
| Q2 24 | $1.7M | $-2.2M | ||
| Q1 24 | $3.1M | — |
毛利率CFBKPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率CFBKPLX
| Q4 25 | 43.4% | -51.1% | ||
| Q3 25 | 17.5% | 11.9% | ||
| Q2 25 | 41.1% | 7.5% | ||
| Q1 25 | 39.5% | -41.0% | ||
| Q4 24 | 36.9% | 39.6% | ||
| Q3 24 | 40.4% | 22.2% | ||
| Q2 24 | 15.4% | -18.0% | ||
| Q1 24 | 30.9% | — |
净利率CFBKPLX
| Q4 25 | 40.0% | -60.3% | ||
| Q3 25 | 15.1% | 13.2% | ||
| Q2 25 | 32.3% | 1.0% | ||
| Q1 25 | 31.4% | -35.8% | ||
| Q4 24 | 35.2% | 35.6% | ||
| Q3 24 | 32.2% | 18.0% | ||
| Q2 24 | 13.5% | -16.4% | ||
| Q1 24 | 25.2% | — |
每股收益（稀释后）CFBKPLX
| Q4 25 | $0.88 | $-0.06 | ||
| Q3 25 | $0.36 | $0.03 | ||
| Q2 25 | $0.77 | $0.00 | ||
| Q1 25 | $0.68 | $-0.05 | ||
| Q4 24 | $0.68 | $0.10 | ||
| Q3 24 | $0.65 | $0.03 | ||
| Q2 24 | $0.26 | $-0.03 | ||
| Q1 24 | $0.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $259.0M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $184.4M | $48.2M |
| 总资产 | $2.1B | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CFBKPLX
| Q4 25 | $259.0M | $14.7M | ||
| Q3 25 | $272.4M | $13.6M | ||
| Q2 25 | $275.7M | $17.9M | ||
| Q1 25 | $241.0M | $19.5M | ||
| Q4 24 | $235.3M | $19.8M | ||
| Q3 24 | $233.5M | $27.4M | ||
| Q2 24 | $241.8M | $23.4M | ||
| Q1 24 | $236.9M | — |
股东权益CFBKPLX
| Q4 25 | $184.4M | $48.2M | ||
| Q3 25 | $179.3M | $52.9M | ||
| Q2 25 | $177.0M | $49.9M | ||
| Q1 25 | $172.7M | $45.2M | ||
| Q4 24 | $168.4M | $43.2M | ||
| Q3 24 | $164.0M | $32.4M | ||
| Q2 24 | $159.6M | $28.6M | ||
| Q1 24 | $158.0M | — |
总资产CFBKPLX
| Q4 25 | $2.1B | $82.3M | ||
| Q3 25 | $2.1B | $82.3M | ||
| Q2 25 | $2.1B | $78.5M | ||
| Q1 25 | $2.1B | $73.9M | ||
| Q4 24 | $2.1B | $73.4M | ||
| Q3 24 | $2.1B | $61.6M | ||
| Q2 24 | $2.0B | $91.5M | ||
| Q1 24 | $2.0B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.7M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $18.2M | $1.6M |
| 自由现金流率自由现金流/营收 | 115.6% | 17.8% |
| 资本支出强度资本支出/营收 | 3.1% | 4.4% |
| 现金转化率经营现金流/净利润 | 3.26× | — |
| 过去12个月自由现金流最近4个季度 | $33.4M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流CFBKPLX
| Q4 25 | $18.7M | $2.0M | ||
| Q3 25 | $5.5M | $-3.7M | ||
| Q2 25 | $8.0M | $-5.2M | ||
| Q1 25 | $2.2M | $-5.1M | ||
| Q4 24 | $14.2M | $4.0M | ||
| Q3 24 | $-1.3M | $4.1M | ||
| Q2 24 | $4.0M | $-3.6M | ||
| Q1 24 | $-1.2M | — |
自由现金流CFBKPLX
| Q4 25 | $18.2M | $1.6M | ||
| Q3 25 | $5.2M | $-4.2M | ||
| Q2 25 | $7.8M | $-5.7M | ||
| Q1 25 | $2.2M | $-5.4M | ||
| Q4 24 | $13.9M | $3.6M | ||
| Q3 24 | $-1.3M | $4.0M | ||
| Q2 24 | $4.0M | $-3.8M | ||
| Q1 24 | $-1.2M | — |
自由现金流率CFBKPLX
| Q4 25 | 115.6% | 17.8% | ||
| Q3 25 | 33.6% | -23.7% | ||
| Q2 25 | 50.3% | -36.2% | ||
| Q1 25 | 15.2% | -53.0% | ||
| Q4 24 | 99.6% | 19.6% | ||
| Q3 24 | -9.9% | 22.4% | ||
| Q2 24 | 31.6% | -28.1% | ||
| Q1 24 | -9.5% | — |
资本支出强度CFBKPLX
| Q4 25 | 3.1% | 4.4% | ||
| Q3 25 | 1.7% | 2.8% | ||
| Q2 25 | 0.7% | 2.8% | ||
| Q1 25 | 0.4% | 3.0% | ||
| Q4 24 | 1.9% | 2.3% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.0% | — |
现金转化率CFBKPLX
| Q4 25 | 3.26× | — | ||
| Q3 25 | 2.34× | -1.58× | ||
| Q2 25 | 1.58× | -31.91× | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 3.21× | 0.61× | ||
| Q3 24 | -0.30× | 1.27× | ||
| Q2 24 | 2.35× | — | ||
| Q1 24 | -0.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CFBK
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
